Cabaletta Bio Income Statement (2018-2026) | CABA

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity) (Quarter)
20.42M21.53M4.26M6.09M29.01M29.01M6.01M7.95M1.86M1.85M8.14M9.83M0.51M48.85M11.23M14.07M61.88M96.27M66.93M169.55M
Operating items
Research & Development (Quarter)
7.85M8.17M9.92M9.17M9.51M8.22M12.40M12.44M11.80M13.79M-36.64M0.37M23.43M26.29M23.00M0.54M37.64M0.58M140.79M44.43M
Selling, General & Administrative (Quarter)
3.29M3.39M3.97M3.83M3.55M3.56M3.90M4.52M4.09M4.88M5.74M6.08M6.85M6.76M8.25M8.12M8.27M6.76M6.42M7.59M
Other Operating Expenses (Quarter)
54.04M21.59M28.48M-0.06M0.50M-0.08M-0.08M
Operating Expenses (Quarter)
11.14M11.56M13.89M13.00M13.06M11.78M16.30M16.96M15.89M18.67M23.15M28.03M30.28M33.05M33.78M37.14M45.91M46.59M42.61M52.02M
Operating Income (Quarter)
-11.14M-11.56M-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.78M-37.14M-45.91M-46.59M-42.61M-52.02M
EBIT (Quarter)
-11.14M-11.56M-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.78M-37.14M-45.91M-46.59M-42.61M-52.02M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.00M0.01M0.05M0.15M0.35M0.61M1.10M1.40M2.22M2.26M2.98M2.68M2.42M1.95M1.49M1.41M1.81M1.33M1.60M
Net income details
EBT (Quarter)
-19.56M-28.04M-13.89M-23.46M-22.66M-17.64M-18.60M-34.09M-56.42M-75.33M-19.18M-94.81M-41.03M-45.85M-32.73M-41.13M-49.06M-66.93M-48.51M-70.39M
Profit After Tax (Quarter)
-11.14M-11.56M-13.88M-12.95M-12.91M-11.43M-15.74M-15.85M-14.49M-16.45M-20.78M-25.05M-27.60M-30.60M-32.59M-35.94M-45.13M-44.87M-41.92M-51.02M
Income from Non-Controlling Interests (Quarter)
0.00M-0.00M0.01M-0.15M-0.10M0.04M0.16M0.05M-0.00M-0.02M0.11M-0.08M0.01M0.03M-0.00M0.00M0.02M0.00M
Income from Continuing Operations (Quarter)
-19.56M-28.04M-13.89M-23.46M-22.66M-17.64M-18.60M-34.09M-56.42M-75.33M-19.18M-94.81M-41.03M-45.85M-32.73M-41.13M-49.06M-66.93M-48.51M-70.39M
Consolidated Net Income (Quarter)
-19.56M-28.04M-13.89M-23.46M-22.66M-17.64M-18.60M-34.09M-56.42M-75.33M-19.18M-94.81M-41.03M-45.85M-32.73M-41.13M-49.06M-66.93M-48.51M-70.39M
Income towards Parent Company (Quarter)
-19.56M-28.04M-13.89M-23.46M-22.66M-17.64M-18.60M-34.09M-56.42M-75.33M-19.18M-94.81M-41.03M-45.85M-32.73M-41.13M-49.06M-66.93M-48.51M-70.39M
Net Income towards Common Stockholders (Quarter)
-19.56M-28.04M-13.89M-23.46M-22.66M-17.64M-18.60M-34.09M-56.42M-75.33M-19.18M-94.81M-41.03M-45.85M-32.73M-41.13M-49.06M-66.93M-48.51M-70.39M
Additional items
EPS (Basic) (Quarter)
-0.96-1.30-3.26-3.85-0.89-0.69-3.09-4.29-30.32-40.68-2.36-9.64-80.78-2.91-2.92-0.79-0.65-0.72-0.47
EPS (Diluted) (Quarter)
-0.79-1.09-0.54-0.81-0.78-0.61-0.63-0.96-1.44-1.71-0.47-1.92-0.83-0.93-0.66-0.83-0.99-1.35-0.98-0.47
Shares Outstanding (Quarter)
20.42M21.53M4.26M6.09M25.40M25.60M6.01M7.95M1.86M1.85M8.14M9.83M0.51M11.23M14.07M61.88M102.26M66.93M151.16M
Shares Outstanding (Diluted) (Quarter)
24.73M25.85M25.74M28.96M28.99M29.01M29.34M35.45M39.17M43.96M40.95M49.30M49.45M49.47M49.52M49.52M49.52M49.52M49.52M151.16M
EBITDA (Quarter)
-11.14M-11.56M-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.78M-37.14M-45.91M-46.59M-42.61M-52.02M
Interest Expenses (Quarter)
8.42M16.48M0.00M10.51M9.75M6.21M2.91M18.24M41.94M58.88M-1.71M69.77M13.43M15.22M0.89M5.48M4.57M22.15M7.22M19.98M